IQVIA Holdings (IQV) reported $3.83 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 2.5%. EPS of $2.70 for the same period compares to $2.54 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $3.77 billion, representing a surprise of +1.55%. The company delivered an EPS surprise of +2.66%, with the consensus EPS estimate being $2.63.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how IQVIA performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Backlog: $31.5 billion compared to the $31.43 billion average estimate based on two analysts.
- Revenues- Technology & Analytics Solutions: $1.55 billion versus $1.52 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +6.4% change.
- Revenues- Research & Development Solution: $2.10 billion versus the six-analyst average estimate of $2.08 billion. The reported number represents a year-over-year change of +0.3%.
- Revenues- Contract Sales & Medical Solutions: $181 million versus the six-analyst average estimate of $183.42 million. The reported number represents a year-over-year change of -4.2%.
- Segment Profit- Technology & Analytics Solution: $360 million versus the four-analyst average estimate of $365.56 million.
- Segment Profit- Contract Sales & Medical Solutions: $11 million versus $15.65 million estimated by four analysts on average.
- Segment Profit- Research & Development Solutions: $460 million versus $471.69 million estimated by four analysts on average.
View all Key Company Metrics for IQVIA here>>>
Shares of IQVIA have returned -0.5% over the past month versus the Zacks S&P 500 composite's +11.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
IQVIA Holdings Inc. (IQV): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
